PrimeRFP SCOUT · Federal Contract Recompete Brief

12805B22F0281Infectious disease diagnostics package — Biofire Defense, LLC

Biofire Defense, LLC holds $41.2M across 235 federal awards, concentrated at Department of Health and Human Services (HHS). This PIID sits alongside 5 related awards under parent 47QSWA18D009D. The prior award was single-bid — competitive dynamics may favor a challenge. PoP ended Oct 22, 2022 — the usual 12–18 month planning window is closed; recompete action looks late or overdue.

Usda Ars Pa Aao Acq/Per Prop

Awarding office

Biofire Defense, LLC

Recipient

Oct 22, 2022

PoP end

$231K

Obligated

$231K

Potential

334516

NAICS

6640

PSC

1 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Biofire Defense, LLC — $90

Contract facts

Federal

Contract number12805B22F0281

Also listed as12805B-22-F-0281

Also listed as47QSWA18D009D-12805B22F0281

AgencyUsda Ars Pa Aao Acq/Per Prop

Awarding officeUsda Ars Pa Aao Acq/Per Prop

Awarding agencyDepartment of Agriculture (USDA)

Funding agencyDepartment of Agriculture (USDA)

IncumbentBiofire Defense, LLC

CAGE088J2

UEINHMDGM122546

NAICS334516

No full NAICS 334516 intel page yet. Browse NAICS intelligence

PSC6640

Parent IDIQ / IDV47QSWA18D009D

Place of performanceMANHATTAN KS

Pricing typeFirm Fixed Price

Extent competedFull And Open Competition

Related solicitation12805B22Q0625

PoP startSep 22, 2022

PoP end (current)Oct 22, 2022

Obligated$231K

Current value$231K

Potential value$231K

INFECTIOUS DISEASE DIAGNOSTICS PACKAGE is a federal award for Usda Ars Pa Aao Acq/Per Prop held by Biofire Defense, LLC. Estimated value $231K ($231K obligated). Current period of performance ends Oct 22, 2022. Last award drew 1 bidder. Place of performance: MANHATTAN KS. Related solicitation 12805B22Q0625.

Recompete timing

Public

● Past PoP end (1399 days ago)

Current PoP ended Oct 22, 2022 (1399 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.

Incumbent footprint

Public record

Biofire Defense, LLC — $41.2M obligated across 235 awards (firm-wide, all agencies) · lead buyer Department of Health and Human Services (HHS).

% of firm-wide obligated ($41.2M) · all agencies

Department of Health and Human Services (HHS)$23.8M · 58%Department of Defense (DOD)$14.4M · 35%Department of State (DOS)$2.8M · 7%General Services Administration (GSA)$104K · 0%

Open full company profile →

Related awards

Same parent · incumbent

N3239825FA005

RESPIRATORY PANELS

$313K

Sep 15, 2026

W81K0225FA133

EQUIPMENT LEASE CONTRACT FOR TWO MULTIPLEX MOLECULAR ANALYZER SYSTEMS AND THE SUPPLY OF TE…

$968K

Sep 30, 2026

W911SR26FA022

THE CONTRACTOR SHALL CONDUCT AN ENGINEERING STUDY TO DEFINE A RAPID DIAGNOSTIC DEVELOPMENT…

$272K

Oct 13, 2026

75A50122C00057

THE OVERALL OBJECTIVE OF THIS CONTRACT IS TO ADVANCE THE DEVELOPMENT OF THE REVEAL RAPID A…

$12.4M

Dec 31, 2026

19AQMM24P0173

EXTENDED PRODUCT WARRANTY FOR THE FILMARRAY EQUIPMENT.

$262K

Jan 20, 2027

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract 12805B22F0281?

12805B22F0281 (Infectious disease diagnostics package) is a Usda Ars Pa Aao Acq/Per Prop award with a potential value of $231K, currently held by Biofire Defense, LLC. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is 12805B-22-F-0281?

12805B-22-F-0281 is the dashed form of PIID 12805B22F0281 (Infectious disease diagnostics package), held by Biofire Defense, LLC. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded 12805B22F0281?

Usda Ars Pa Aao Acq/Per Prop awarded 12805B22F0281 to Biofire Defense, LLC (potential $231K).

Who is the incumbent on 12805B22F0281?

Biofire Defense, LLC is the incumbent with $41.2M across 235 related awards in SCOUT’s public footprint. The current period of performance ends Oct 22, 2022.

When does Biofire Defense, LLC’s 12805B22F0281 come up for recompete?

SCOUT tracks a period-of-performance end of Oct 22, 2022. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Jun 25, 2026 · refreshed monthlyLatest procurement action Sep 22, 2022